Bremer Trust National Association’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
$718K Sell
3,689
-571
-13% -$111K 0.16% 142
2018
Q3
$883K Sell
4,260
-677
-14% -$133K 0.22% 121
2018
Q2
$912K Sell
4,937
-5,145
-51% -$910K 0.25% 118
2018
Q1
$1.72M Sell
10,082
-335
-3% -$61.5K 0.5% 60
2017
Q4
$1.81M Buy
10,417
+722
+7% +$128K 0.49% 61
2017
Q3
$1.81M Buy
9,695
+171
+2% +$30.3K 0.5% 59
2017
Q2
$1.64M Buy
9,524
+408
+4% +$66.4K 0.47% 69
2017
Q1
$1.5M Buy
9,116
+1,674
+22% +$278K 0.4% 76
2016
Q4
$1.09M Buy
7,442
+4,984
+203% +$750K 0.3% 96
2016
Q3
$410K Buy
+2,458
New +$416K 0.11% 182

Other funds holding AMGN

Bremer Trust National Association's AMGN Position: Q4 2018 in Review

Bremer Trust National Association reduced its Amgen (AMGN) stake by 13% in Q4 2018, selling an estimated $111K and leaving 3,689 shares worth $718K. The position accounts for 0.16% of the portfolio, ranked #142.

Bremer Trust National Association first reported a position in AMGN in Q3 2016 and has held it in 10 quarters since. The position peaked at $1.81M in Q4 2017. 1,892 funds tracked by Wall St. Rank hold AMGN as of Q4 2018.

  • Bremer Trust National Association held 3,689 shares of Amgen worth $718K as of Q4 2018.
  • Bremer Trust National Association sold 571 Amgen shares in Q4 2018, an estimated $111K.
  • Amgen made up 0.16% of Bremer Trust National Association's portfolio in Q4 2018, its #142 holding.
  • Bremer Trust National Association first reported a position in Amgen in Q3 2016 and has held it in 10 quarters since.
  • Bremer Trust National Association's Amgen position peaked at $1.81M in Q4 2017.
  • 1,892 funds tracked by Wall St. Rank held Amgen as of Q4 2018.

Based on Bremer Trust National Association's 13F filing for Q4 2018, filed 11 Feb 2019.